DigiLab

The National Institutes of Health has awarded a team of Harvard University researchers nearly $300,000 to develop a new microarray platform capable of imaging millions of bacterial cells in an overnight experiment.

Under the terms of the deal, Holliston, Mass.-based Digilab will sell Axela's Ziplex system for gene and protein expression analysis and dotLab mX system for real-time immunoassays.

The deal calls for Digilab to market new versions of Axela's proprietary flow-through technologies, the Ziplex system and the dotLab mX system.

Nearly four years after it acquired Harvard Bioscience's Genomic Solutions business, DigiLab is looking to parlay those microarray assets into the market for live cell arrays, and the stem cell research market in particular.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.